Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript Summary
Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript Summary
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.The following is a summary of the Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript:
以下是accelerate diagnostics, Inc. (AXDX) 2024年第三季度業績發佈會文字實錄摘要:
Business Progress:
業務進展：
Accelerate Diagnostics is expanding its WAVE system and Gram-Negative testing menu with successful clinical trial progresses and site enrollments.
accelerate diagnostics正在擴展其WAVE系統和革蘭氏陰性測試菜單，成功進行臨床試驗並招募研究網站。
Opportunities:
機會：
The ongoing development and rollout of the WAVE system represents a market expansion within the diagnostic segment, especially targeting Gram-Negative testing.
WAVE系統的持續發展和推出代表了診斷領域的市場擴張，特別針對革蘭氏陰性測試。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
